Work

Editorial

Year: 2009
Type: editorial
Abstract: Scandinavian Journal of Immunology has established itself over the last 35 years as one of the leading journals in the field through the publication of high quality original papers and reviews that reflect the developments in this discipline. The journal has made great strides in the last couple of years in particular, and we would like to bring you up to date on some of the changes made and on our plans for the future. The total circulation of the journal is now well over 7000. Nearly 4000 institutions in the developing world now enjoy free or very low rate paid access to Scandinavian Journal of Immunology through various philanthropic initiatives (INTAS, INASP, Research4Life [HINARI-WHO], AGORA). More than 60% of the subscribers to the journal are currently online only. Articles from Scandinavian Journal of Immunology were downloaded a massive 149000 times in 2008. The journal’s top users in 2008 reflect its international appeal: those most frequently downloaded articles were Tameside Hospital (Manchester, UK); Roche, Palo Alto; NLM, Stanford; Sao Paulo University; Harvard; the Karolinska Institute; the Medical Faculty of Sao Jose, Rio Preto, Brazil; the Oswald Cruz Foundation and the University of Pittsburgh. Nearly 1400 researchers have subscribed to the e-toc alert service, through which tables of contents are sent direct to their Inbox. There are no page charges or submission fees for authors publishing in the journal. Reviews are freely accessible online and colour reproduction is free to review authors. Author-funded open access is available for authors whose funding bodies mandate publication in an open access journal. Members of immunological societies can receive the journal at the privileged rate of £30. All papers for Scandinavian Journal of Immunology are now submitted and refereed online using Manuscript Central. This has led to enormous savings in the time from submission to acceptance; the average handling time for a paper is now 26 days from submission to first decision and 43 days from submission to final decision. There is also a fast-track facility available for the highest profile papers. In 2008 publication times became even faster, with the author’s final accepted version being made available online within 5 days of acceptance by the editorial office. This means that articles from Scandinavian Journal of Immunology are downloadable and citable faster than ever. The journal operates a stringent peer review process, and all referees are given feedback on the decisions made on the papers they have reviewed. The year 2008 saw a further increase in Scandinavian Journal of Immunology’s impact factor – it rose from 1.928 in 2007 to 2.186 in 2008. Review articles receive two to three times as many citations as original articles: in 2008, the most highly cited 2007 article was the very thorough review [1]. With published contributions from corresponding authors in 31 countries around the world (Figure 1), Scandinavian Journal of Immunology is truly international in outlook. With great pleasure we present the ECI2009 issue of Scandinavian Journal of Immunology, which is also distributed to participants of the 2nd Pan-European Immunology Meeting. It is our sincere hope that the content of this issue with some invited papers produced by Editorial Board members [2–9], without emphasizing any particular immunological topic or subject, reflects the broad international profile of the Journal. Country related number of contributions to Scandinavian Journal of Immunology in 2008.
Language: Spanish
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W4232471762
Cites: 9
Cited by:
Related to: 10